Meta Biomed Co. Ltd (059210) — Cash Flow Quality Index
Meta Biomed Co. Ltd (059210) has a Cash Flow Quality Index of 0.24x as of September 2025. Operating cash flow of ₩1.05 Billion is below net income of ₩4.46 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore cash efficiency ratio of Meta Biomed Co. Ltd to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Meta Biomed Co. Ltd Cash Flow Quality Index (2011–2024)
Historical Cash Flow Quality Index for Meta Biomed Co. Ltd across 10 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 059210 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Meta Biomed Co. Ltd (2011–2024)
Year-by-year earnings quality comparison for Meta Biomed Co. Ltd. For live market cap and the full company financial profile, see Meta Biomed Co. Ltd market cap and net worth.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.01x | ₩22.63 Billion | ₩22.32 Billion | ▼ -2.6% |
| 2023 | 1.04x | ₩10.22 Billion | ₩9.82 Billion | ▼ -70.1% |
| 2022 | 3.49x | ₩9.16 Billion | ₩2.63 Billion | ▲ +198.0% |
| 2021 | 1.17x | ₩11.14 Billion | ₩9.52 Billion | ▲ +36.6% |
| 2019 | 0.86x | ₩2.86 Billion | ₩3.35 Billion | ▼ -87.3% |
| 2016 | 6.72x | ₩5.03 Billion | ₩748.74 Million | ▲ +32.1% |
| 2015 | 5.09x | ₩4.93 Billion | ₩969.74 Million | ▲ +197.5% |
| 2013 | 1.71x | ₩3.71 Billion | ₩2.17 Billion | ▲ +4.0% |
| 2012 | 1.64x | ₩3.83 Billion | ₩2.33 Billion | ▼ -52.8% |
| 2011 | 3.48x | ₩4.10 Billion | ₩1.18 Billion | — |